FDA Approval Update for Methylergomovine Maleate by Amneal Pharmaceuticals
The FDA has accepted the supplemental application ANDA211483 for Methylergonovine Maleate submitted by Amneal Pharmaceuticals.
Therapeutic Area
Therapeutic area intelligence for Uterotonics with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.